This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC

CPC 2022 Programme

Subpage Hero



A holistic approach to anticoagulation and shared decision making in patients with NVAF

13 May 2022
A holistic approach to anticoagulation and shared decision making in patients with NVAF







This session has been fully organised and funded by Bayer and contains promotional content. Adverse event reporting and prescribing information is available at the end of the presentation.

This presentation will focus on the ‘protect’ and ‘perfect’ elements of the Academic Health Science Network (AHSN) Atrial Fibrillation programme, examining how oral anticoagulation can be optimised for patients with non-valvular atrial fibrillation (NVAF) in line with current guidance, taking into consideration common co-morbidities such as diabetes and renal impairment. It will also explore considerations around dosing and adherence, patient preferences, shared decision-making and the role of structured medication reviews when managing patients with NVAF.

RP-XAR-GB-4124, March 2022


Mrs Alison Warren, Consultant Pharmacist - Sussex Clinical Commissioning Groups and University Hospitals Sussex
Mrs Beverley Bostock, Advanced Nurse Practitioner - Mann Cottage Surgery, PCN Nurse Coordinator, Hereford


Lead Education Partner

  • CPPE
  • Morph


Education Partner

  • BOPA
  • BPNG
  • CMHP
  • Health Education England


Education Partner

  • NHS England and NHS Improvement
  • NHS Digital
  • NHSx
  • PTOC
  • GPHC


Education Partner

  • NPPG
  • PCPA
  • PDA
  • Pharmacist Support
  • RPUK
  • SPS


Education Partner

  • Soar Beyond
  • NHCA
  • PrescQIPP
  • Pharmacy Declares
  • GHP and RPS


Media Partner

  • C&D
  • PDA
  • PrescQIPP
  • Scottish Healthcare Review
  • Welsh Healthcare Review
  • NI Healthcare Review
  • Prescriber


Nominated Charity

  • Pharmacist Support


Newsletter Sign Up